View Article

Abstract

Matrix tablets of Paracetamol were prepared utilizing natural polymer chitosan. The tablets represented sustained drug release which is required for the drugs like Paracetamol with low bioavailability and low half life. The tablets can sustain the drug release which can overcome such problems. Moreover the tablets contain chitosan which also is a permeability enhancer and hence could be utilized to increase the permeability of the drugs like Paracetamol with very low permeability. The tablets possess high potential for being developed as sustained release dosage forms for drugs with low permeability , bioavailability and lower half life.

Keywords

Matrix tablets, Paracetamol, natural polymer, chitosan, bioavailability

Introduction

Oral route is one of the most popular routes of drug delivery due to its ease of administration, patient compliance, least sterility constraints and flexible design of dosage form (Indian Pharmacopoeia).

Tablets: Over 90% of the formulations manufactured today are ingested orally. This shows that this class of formulation in the most popular worldwide and the major attention of the researcher is toward this direction.  With advanced in technology and increase in awareness, toward modification in standard tablets is done to achieve better acceptability as well as bioavailability because of which newer and more efficient tablet dosage forms are being developed. The main reasons behind formulation of different type of the tablets are to create a delivery system that is relatively simple and in expensive to manufacture, provide the dosage form that is convenient from patients perspective and utilize an approach that is unlikely to add complexity during regulatory approval process. To understand each dosage form, tablets here are classified by their route of adrninistration and by the type of drug delivery system they represent within route.

Overview on types and class of tablets:

  1. Tablet lngested Orally:

These tablets are meant to be swallowed intact along with sufficient quantity of the potable water. Exception are chewable tablet and oral dispersible tablets. Standard compressed tablets this class includes tablets like, multiple compressed tablets, compression coated tablets, layered tablets, modified released tablets etc.

  1. Tablets used in the oral cavity:

The tablets under this group are airned to released active pharmaceutical ingredient in the oral cavity or to provide local action in this region. The tablets under this category avoids first-pass metabolism, decomposition in gastric environrnent, nauseatic sensations and gives rapid onset of action. The tablets fommlated for this region are designed to fit in proper region of oral cavity. This class includes tablets like lozenges and troches, sublingual tablets, buccal tablets, dental eones, oral dispersible tablet etc.

  1. Tablets administered by other routes:

These tablets are administered by other route except for the oral cavity and so the drugs are avoided from passing through gastrointestinal tract. These tablets may be inserted into other body cavities or directly placed below the skin to the absorb into systemic circulation from the site of application. This class include tablets vaginal tablets, implants etc.

  1. Tablets used to prepare solution:

The tablets under this category are required to be dissolved first in water or other solvent before administration or application. This solution may be for ingestion or parenteral application or for topical use depending upon type of medicament used. This class includes tablets like effervescent tablet, hypodermic tablet etc.

Matrix Tablets:

Definition:

Matrix tablets are the type of tablet which is designed such that it releases it contents regarding first order kineticks or zero order kinetics due to special arrangement and combination of hydrophobic and hydrophilic polymers as an excipient to form a matrix. example of such a matrix tablets are, controlled release tablet, sustained released tablet. these all come under the category of modified release tablet.

MATERIAL AND METHOD:

Preformulation study: Pre-formulation may be described as a phase the research and development process where the formulation scientist characterizes the physical, chemical and mechanical properties of new drug substances, in order to develop stable, safe and effective dosage forms. Ideally the pre-formulation phase begins early in the discovery process such that the appropriate physical and chemical data is available to aid the selection of the new chemical entities that enter the development process. During this evaluation, possible interactions with various inert ingredients intended for use in final dosage form is also considered in the present study. The following data must be considered.

Table 1: Preliminary screening of formulation of sustained release layer of paracetamol using natural, hydrophillic and hydrophobic polymers

lngredients(mg)

SRl

SR2

SR3

SR4

SRS

Paracetamol

50

50

50

50

50

HPMC 15cps

35

55

75

-

-

Na- CMC

70

50

30

25

30

Gar Gum

-

-

-

45

40

Mg- Stearate

3.5

3.5

3.5

3.5

3.5

Lactose

188

188

188

223

223

Tale

3.5

3.5

3.5

3.5

3.5

Total

350

350

350

350

350

Organoleptic property:

Table no 2.: Description of the drug (Paracetamol).

S NO.

Description

Paracetamol drug

1

State

Solid

2

Colour

White or yeUowish

3

Odour

Odourless

4

Texture

Amorphous powder

Solubility studies:

An excess quantity of Paracetamol was taken separately and add in 1O ml of different solutions. These solutions were shaken well for few minutes. Then the solubility was observed and observations are shown in the table no.3.2-

Table no 3: Solubility studies of drug in different solvents.

Solvents

Solubility of Paracetamol

Water

Freely soluble

Methanol

Soluble

Acetone

Insoluble

Alcohol

Sparingly soluble

Methylene chloride

Practically insoluble

Partition coefficient:

It is a measurement of drug's hydrophilicity and an indication of its ability to cross cell membranes, partition coefficient of Paracetamol was found out by suspending known amount of drug in 1:1 mixture of octanol/water. The concentration of the drug in oil and water was determined through the absorbance of the dilution of the drug

Table no 4 Partition coefficient of drug

Drug

Specification (Log P value)

Observation (Log P value)

Paracetamol

-8.08

-7.98

Loss on drying studies:

About 1g of the powder was weighted and kept for checking the loss on drying on a moisture sensitive balance at 105°C for 3 minute % loss of moisture was 8%.

pH of the solution:

The pH study was done for the drug by dissolving it in their water as solvent and determining the pH while the help of pH meter. The pH value of clrug has been shown in tableno.3.4.

Table no. 5 pH of drug solution

Drug

Specification

Observation

Paracetamol

5.5-7.5

6.8

Melting point:

Melting point of the clrug was determined by the Theil 's Apparatus. It can be performed by filling of the drug in capillary tube and tied this capillary tube at the bottom of thermometer with the help of thread. Now filled Theil's with light liquid paraffin and holded this tube with the help of burette stand than place burner at the bottom of tube, dip the thermometer in this liquid paraffin and the note the point which drug started melting in the capillary. Melting point of drug has been shown in the table no 3.3.

Table no 6 Melting point of drug

Drug

Specification

Observation

Paracetamol

I 46-I48°C

I47- I49°C

Standard calibration curve for Paracetamol:

Preparation of standard solution:

For preparation of standard solution, I Omg of drug was dissolved in IO ml of distilled water (upto IO ml). This is stock solution.

Preparation of sample:

Prepared O.O IN KMn04 solution and O. IN NaOH solution and mixed 5ml of KMn04 of the solution in 5ml of NaOH solution. Withdrawn O.I, 0.2,0.3,0.4,0.5 ml from stock solution and added 5ml of mixture of KMn04 in NaOH solution and up to volume upto I Oml with the help of distilled water. Drug solution was scanned on UV Visible spectrophotometer to obtain A.max of the drug which was found to be 6IO nm. Absorbance of different aliquots was measured at the A.max specific for that drug on UV Visible spectrophotometer (Model: UV - 1700 Shimadzu, Japan) at 6I Onm. Linear regressed calibration curve was constructed which has been represented in graph given table no 3.6.

Table no 7: Absorbance of different aliquots of Paracetamol at 610 nm

Reference

  1. Al-Shammary AAG, Kouzani AZ, Kaynak A, Khoo SY,
  2. Norton M, Gates W. Soil Bulk Density Estimation Methods: A Review. Pedosphere. 2018;28(4):581-596.
  3. Gupta MM, Brijesh R. A Review On: Sustained Release Technology. Int J Ther Appl. 2012;8: 18-23.
  4. The Chemistry  Notes.  How to prepare 0.1 N HCL  solution  [Internet].  2023 Dec 13 [cited 2023 Dec 13]. Available from: https://thechemistrynotes.com/how-to-prepare-0- 1-n-hcl-solution/ Bardanzellu F., Neroni P., Dessi A., Fanos V. Paracetamol in patent ductus arteriosus treatment:  efficacious and safe?  Biomed.  Res.  Int.  2019; 2019: 1438038.
  5. "Handbook of Pharmaceutical Excipients" (Latest Edition) by Rowe, Sheskey & Quinn Provides details on natural and synthetic polymers used in drug formulation.
  6. European Medicines Agency. ICH Ql(R2) Stability testing of new drug substances and products           [Intemet].2023           Dec    31        [cited   2023    Dec      31].      Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q- l-r2- stability-testing-new-drug-substances-and-products-step-5   _en.pdf
  7. Rajesh R, Navya V, Kumar SK. Importance of Drug Excipient Compatibility Studies by Using or Utilizing Or Employing Various Analytical Techniques-An Overview. IJPSR.  2022;13(9):3473-3485.
  8. Azimuddin A, Roslan MF, Widodo RT. Formulation and in vitro Evaluations of Low Dose Paracetamol Orally Disintegrating Tablets. J. Food Pharm Sci.2023;11(1):780- 787
  9. Poreddy SR, Penjuri SCB, Damineni S, Vuppula S. Formulationand evaluation of colon targeted matrix tablet using natural tree gums. Int J Pharm Pharm Sci 2018; 10:92-7.
  10. Cook S.F., Stockmann C., Samiee-Zafarghandy S., King A.D., Deutsch N., Williams E.F. et al. Neonatal maturation of paracetamol (acetaminophen) glucuronidation, sulfation, and oxidation based on a parent-metabolite population pharmacokinetic model. Clin. Pharmacokinet. 2018; 55(11): 1395-411.
  11. Manna S, Jayasri K, Annapuma KR, Kanthal LK. Alginate-based gastro-retentive raft­ forming tablets for enhanced bioavailability of tinidazole. Int J Appl Pharm 2017; 9:16- 21.
  12. 11. Brayfield A., ed. Martindale: The Complete Drug Reference. London, UK: Pharrnaceutical Press; 2016.
  13. 12. U.S. Food and Drug Adrninistration (FDA). Page Last Updated: January 16, 2014.
  14. "Pharrnaceutical Dosage Forrns: Tablets" (3rd Edition) by Larry L. Augsburger & Stephen W. Hoag - Covers tablet forrnulation principies.
  15. "Handbook of Pharrnaceutical Excipients" (Latest Edition) by Rowe, Sheskey & Quinn Provides details on natural and synthetic polyrners used in drug formulation.
  16. "Polyrners for Controlled Drug Delivery" by Dirnitrios T. Papageorgiou - Discusses natural and synthetic polyrners in drug release.
  17. "Polyrners for Controlled Drug Delivery” by Dirnitrios T. Papageorgiou - Discusses natural and synthetic polyrners in drug release.
  18. Basavaraj C, Sorneswara Rao B, S.V Kulkarni, Patil Prarnod, Surpur Chetan; "Design and Characterization of Sustained Release Aceclofenac Matrix Tablets Containing Tarnarind Seed Polysaccharide"; Asian J Pharm. Tech; 2011; 1(1): 17-21
  19. Chandira Margret, V. Muruganantharn, Debjit, Kurnudhavalli, Jatakar          B.; "Fommlation And Evaluation of Sustained Release Matrix Tablets of Zidovudine"; International Joumal of Current Pharrnaceutical Research; 2009;1(1): 14-31.
  20. 1. "Pharrnaceutical Dosage Forrns: Tablets" (3rd Edition) by Larry L. Augsburger & Stephen W. Hoag - Covers tablet forrnulation principies.
  21. Chiasson J.-L., Josse R. G., Gornis R., Hanefeld M., Karasik A., Laakso M.; "Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with irnpaired glucose tolerance: facts and interpretations
  22. "Pharrnaceutics: The Science of Dosage Forrn Design" by Aulton & Taylor - Covers rnatrix tablet formulations and polyrner applications.

Photo
Amit Dubey
Corresponding author

NRI Institute of Pharmaceutical Sciences Bhopal, Madhya Pradesh

Photo
Kusum Kumari
Co-author

NRI Institute of Pharmaceutical Sciences Bhopal, Madhya Pradesh

Photo
Lubna Shaheen
Co-author

NRI Institute of Pharmaceutical Sciences Bhopal, Madhya Pradesh

Photo
Manish Kumar
Co-author

NRI Institute of Pharmaceutical Sciences Bhopal, Madhya Pradesh

Photo
Mo Rayyan
Co-author

NRI Institute of Pharmaceutical Sciences Bhopal, Madhya Pradesh

Photo
Mohammad Saklain
Co-author

NRI Institute of Pharmaceutical Sciences Bhopal, Madhya Pradesh

Photo
Mohd Aarif Khan
Co-author

NRI Institute of Pharmaceutical Sciences Bhopal, Madhya Pradesh

Amit Dubey*, Kusum Kumari, Lubna Shaheen, Manish Kumar, Mo Rayyan, Mohammad Saklain, Mohd Aarif Khan, Formulation and Evaluation of Paracetamol Matrix Tablet Using Natural Polymer, Int. J. Sci. R. Tech., 2025, 2 (5), 542-547. https://doi.org/10.5281/zenodo.15515718

More related articles
Artificial Intelligence in Drug Discovery: Challen...
Dr. Sunil Jaybhayee, Payal Kundkar, Nikita Pungle, ...
A Study of Indigenous Plant Species in Adilabad Fo...
Dr. Pattivar Srinivas, Md. Ashraf Ali, Dr. Dasari Rajkumar, Dr. V...
Emerging Immunomodulatory Strategies in Myasthenia Gravis: Focusing on Cell and ...
Anagha K P, Vigneshwaran M, Gokulnath S, Harshini S, Gnanapriya K, ...
Healthy Economy And “One Health”: Central Pillars of Veterinary Education...
H. Rodríguez Frausto, F. De La Colina Flores, T. De La Colina García, P. De La Colina García, ...
Implementation of Hybrid Soft-Hard Exosuit for Adaptive Ankle Movement Therapy D...
Ranjithkumar S., Krishnaragavan V., Pranitha V. K. J., Harivansh B. R., Dharshini D., ...
More related articles
A Study of Indigenous Plant Species in Adilabad Forest Traditionally Utilized fo...
Dr. Pattivar Srinivas, Md. Ashraf Ali, Dr. Dasari Rajkumar, Dr. Vemuganti Varaprasad Rao, ...